Slotnik Capital, LLC Revance Therapeutics, Inc. Transaction History
Slotnik Capital, LLC
- $221 Billion
- Q4 2024
A detailed history of Slotnik Capital, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Slotnik Capital, LLC holds 671,607 shares of RVNC stock, worth $1.73 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
671,607Holding current value
$1.73 Million% of portfolio
0.92%Shares
1 transactions
Others Institutions Holding RVNC
# of Institutions
223Shares Held
83.3MCall Options Held
816KPut Options Held
882K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I05.1MShares$13.1 Million0.78% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY3.5MShares$8.99 Million0.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...